PROSPECTS AND OPPORTUNITIES
Sales likely to be driven by topical analgesics/anaesthetic and adult acetaminophen despite Trump’s autism claims
Value sales of analgesics are expected to rise over the forecast period overall. The anticipated value gains in topical analgesics/anaesthetic and adult acetaminophen will positively influence the category and help to drive sales value growth.
Digital tools offer tech-based solutions for chronic pain management through tracking and cognitive behavioural therapy
Healthify NZ, the health information platform formerly known as Health Navigator NZ, provides accessible, plain-language online resources to support wellbeing. Among its comprehensive content, it offers reviewed pain management apps to help sufferers of chronic pain to track how their pain affects their daily activities, and tips, tools and techniques to manage pain - such as mindfulness, breathing techniques and cognitive behavioural therapy (CBT).
Paracetamol scheduling under review amid Australian regulatory changes and rising safety concerns
In response to rising concerns about intentional overdose, Australia’s Therapeutic Goods Administration (TGA) introduced new scheduling rules for paracetamol (acetaminophen), announced in May 2023 and effective February 2025. These include tighter pack size limits (16 tablets or capsules in supermarkets and 50 in pharmacies without pharmacist oversight) along with mandatory blister packaging across retail and pharmacy channels.
Delivery:
Files are delivered directly into your account soon after payment is received and any tax is certification is verified (where applicable).
This report comes in PDF with additional info in Excel included.
Overview:
Understand the latest market trends and future growth opportunities for the Analgesics industry in New Zealand with research from Euromonitor International's team of in-country analysts – experts by industry and geographic specialisation.
Key trends are clearly and succinctly summarised alongside the most current research data available. Understand and assess competitive threats and plan corporate strategy with our qualitative analysis, insight and confident growth projections.
If you're in the Analgesics industry in New Zealand, our research will help you to make informed, intelligent decisions; to recognise and profit from opportunity, or to offer resilience amidst market uncertainty.
The Analgesics in New Zealand report includes:
- Analysis of key supply-side and demand trends
- Detailed segmentation of international and local products
- Historic volume and value sizes, company and brand market shares
- Five year forecasts of market trends and market growth
- Robust and transparent research methodology, conducted in-country
This report answers:
- What is the market size of Analgesics in New Zealand?
- Which are the leading brands in Analgesics in New Zealand?
- How are products distributed in Analgesics in New Zealand?
- How has the regulatory and operating environment for Analgesics changed in New Zealand?
- How are considerations such as stress, self-medication and shifting consumer lifestyles shaping demand for Analgesics
- How significant are wider health concerns and consumer awareness in determining sales?
- Where is future growth expected to be most dynamic?
Analgesics in New Zealand - Category analysis
KEY DATA FINDINGS
Growing recognition of chronic pain drives analgesics sales in New Zealand
Leading analgesics players leverage promotional efforts and sports sponsorship investments to build brand awareness locally
Supermarkets and pharmacies continue to shape retail channel dynamics
Sales likely to be driven by topical analgesics/anaesthetic and adult acetaminophen despite Trump’s autism claims
Digital tools offer tech-based solutions for chronic pain management through tracking and cognitive behavioural therapy
Paracetamol scheduling under review amid Australian regulatory changes and rising safety concerns
Consumer Health in New Zealand - Industry Overview
Consumer Health in 2025: The big picture
Key trends in 2025
Competitive landscape
Channel developments
What next for Consumer Health?
OTC registration and classification
Vitamins and dietary supplements registration and classification
Self-medication/self-care and preventive medicine
Switches
DISCLAIMER
DEFINITIONS
The following categories and subcategories are included:
Analgesics
-
-
- Adult Acetaminophen
- Adult Aspirin
- Adult Combination Products - Analgesics
- Adult Diclofenac
- Adult Dipyrone
- Adult Ibuprofen
- Adult Ketoprofen
- Adult Naproxen
- Adult OTC Triptans
-
- Paediatric Acetaminophen
- Paediatric Aspirin
- Paediatric Combination Products - Analgesics
- Paediatric Dipyrone
- Paediatric Ibuprofen
- Paediatric Naproxen
-
- Acetaminophen
- Aspirin
- Combination Products - Analgesics
- Diclofenac
- Dipyrone
- Ibuprofen
- Ketoprofen
- Naproxen
- OTC Triptans
-
- Topical Analgesics/Anaesthetic
Analgesics
Analgesics cover systemic and topical pain relievers. Products which include a pain-relief ingredient in addition to another core function are excluded (e.g. a sore throat remedy which includes paracetamol is excluded from the analgesics and instead is included in pharyngeal remedies).
See all of our definitionsWhy buy this report?
- Gain competitive intelligence about market leaders
- Track key industry trends, opportunities and threats
- Inform your marketing, brand, strategy and market development, sales and supply functions
This report originates from Passport, our Analgesics research and analysis database.
NEW REPORT GUARANTEE
If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extraction Free!